Clinical Trials on Metastatic Prostatic Adenocarcinoma in South Africa
Total 1627 results
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
Oxford BioMedicaMedSource LLCTerminatedHormone Refractory Prostate CancerUnited States
-
Merrion Pharmaceuticals, LLCCompletedHormone-Refractory Prostate CancerUnited States, Estonia, Latvia
-
ImunonCompletedProstate CancerUnited States
-
University of Texas Southwestern Medical CenterCompletedProstate CancerUnited States
-
Sensei Biotherapeutics, Inc.AccelovanceCompleted
-
Medical University of South CarolinaRecruitingProstate CancerUnited States
-
Medical University of South CarolinaActive, not recruiting
-
Amunix, a Sanofi CompanyRecruitingHormone-refractory Prostate CancerAustralia, Spain, United Kingdom
-
Peter MacCallum Cancer Centre, AustraliaUnknownProstate CancerAustralia, New Zealand
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
zr Pharma & GmbHFoundation MedicineCompletedMetastatic Castration Resistant Prostate CancerUnited States, Spain, United Kingdom, France, Australia, Belgium, Denmark, Israel, Germany, Ireland, Canada, Italy
-
NRG OncologyNational Cancer Institute (NCI)SuspendedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8Canada, United States
-
Medical University of South CarolinaRecruitingProstate CancerUnited States
-
Medical University of South CarolinaCompletedProstate CancerUnited States
-
Medical University of South CarolinaTerminatedProstate CancerUnited States
-
Australasian Gastro-Intestinal Trials GroupUniversity of SydneyActive, not recruitingPancreatic Ductal Adenocarcinoma | Metastatic Pancreatic CancerAustralia, New Zealand
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers Squibb; University of Sydney; Advanced Accelerator Applications; Prostate...Active, not recruitingNeoplasms | Urogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Prostate Cancer | Prostatic DiseaseAustralia
-
DisperSol Technologies, LLCTranslational Drug DevelopmentActive, not recruiting
-
Effector TherapeuticsCompletedCastrate-resistant Prostate Cancer (CRPC)United States
-
VA Office of Research and DevelopmentMedical University of South CarolinaCompletedProstate CancerUnited States
-
St Vincent's Hospital, SydneyClarity Pharmaceuticals LtdCompleted
-
CelgeneCompletedMetastatic Pancreas AdenocarcinomaUnited States
-
SonaCare MedicalUnknownProstate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Pellficure Pharmaceuticals, IncTerminatedProstate CancerUnited States, Australia
-
SWOG Cancer Research NetworkProteus Digital Health, Inc.Terminated
-
Dana-Farber Cancer InstituteJanssen Scientific Affairs, LLCActive, not recruiting
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, Australia; Novartis Pharmaceuticals and other collaboratorsCompletedProstate CancerAustralia, New Zealand
-
AstraZenecaParexelCompleted
-
Noxopharm LimitedCompletedCancerNew Zealand, Georgia, Australia
-
Royal North Shore HospitalRecruitingProstate CancerAustralia
-
Clovis Oncology, Inc.CompletedMetastatic Pancreatic AdenocarcinomaUnited States, Belgium, Canada, Australia, United Kingdom, Germany, Italy, Argentina, Russian Federation, France, Brazil, Sweden, Norway, Netherlands, Ukraine
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited States, Canada
-
TakedaTakeda Development Center Americas, Inc.RecruitingUnresectable Locally Advanced or Metastatic CancerSpain, United States, Australia, Canada
-
AstraZenecaCompletedProstate CancerUnited Kingdom, Germany, United States
-
Aragon Pharmaceuticals, Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom, Moldova, Republic of
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate CarcinomaUnited States
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedProstate CancerAustralia, Singapore, Hong Kong
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, South Africa
-
Veru Inc.TerminatedAdvanced Prostate AdenocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; Columbia University; Duke University; Lithuanian University... and other collaboratorsCompletedProstate CancerUnited States, Canada, Lithuania
-
LTN PHARMACEUTICALS, INC.CompletedProstate CancerUnited States
-
Prostate Cancer Clinical Trials ConsortiumRecruitingProstate CancerUnited States, Australia, Spain, Switzerland, United Kingdom, Kenya, Canada, Ireland, Barbados, Brazil, Jamaica, Nigeria, Norway, Sweden, South Africa
-
Progenics Pharmaceuticals, Inc.Completed
-
PRAECIS Pharmaceuticals Inc.CompletedProstate CancerUnited States